Nutrient control of insulin secretion in isolated normal human islets

Diabetes

Volumn 55, Issue 12, 2006, Pages 3470-3477

  Henquin, Jean Claude ^a   Dufrane, Denis ^a   Nenquin, Myriam ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO BICYCLO [2,2,1] HEPTANE 2 CARBOXYLIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CARBOXYLIC ACID DERIVATIVE; DIAZOXIDE; FORSKOLIN; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; INOSINE; INSULIN; LEUCINE; PALMITIC ACID; POTASSIUM CHLORIDE; PYRUVIC ACID; SUCCINIC ACID; TOLBUTAMIDE;

ARTICLE; CELL FUNCTION; DEPOLARIZATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; PANCREAS ISLET; PRIORITY JOURNAL;

GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; KINETICS; PERFUSION; REFERENCE VALUES; TISSUE DONORS;

EID: 33845541249     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0868     Document Type: Article

References (62)

1. Henquin JC, Ravier MA, Nenquin M, Jonas JC, Gilon P: Hierarchy of the β-cell signals controlling insulin secretion. Eur J Clin Invest 33:742-750, 2003
2. Ashcroft SJH, Bassett JM, Randle PJ: Isolation of human pancreatic islets capable of releasing insulin and metabolising glucose in vitro. Lancet 297:888-889, 1971
3. Andersson A, Borg H, Groth CG, Gunnarsson R, Hellerström C, Lundgren G, Westman J, Östman J: Survival of isolated human islets of Langerhans maintained in tissue culture. J Clin Invest 57:1295-1301, 1976
4. Grant AM, Christie MR, Ashcroft SJH: Insulin release from human pancreatic islets in vitro. Diabetologia 19:114-117, 1980
5. Harrison DE, Christie MR, Gray DWR: Properties of isolated human islets of Langerhans: insulin secretion, glucose oxidation and protein phosphorylation. Diabetologia 28:99-103, 1985
6. Rhodes CJ, Campbell IL, Szopa TM, Biden TJ, Reynolds PD, Fernando ON, Taylor KW: Effects of glucose and D-3-hydroxybutyrate on human pancreatic islet cell function. Clin Sci 68:567-572, 1985
7. Misler S, Barnett DW, Gillis KD, Pressel DM: Electrophysiology of stimulus-secretion coupling in human β-cells (Review). Diabetes 41:1221-1228, 1992
8. Kindmark H, Köhler M, Arkhammar P, Efendic S, Larsson O, Linder S, Nilsson T, Berggren PO: Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance. Diabetologia 37:1121-1131, 1994
9. Marchetti P, Scharp DW, Mclear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE: Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43:827-830, 1994
10. ATP channel-dependent and KATP channel-independent signaling pathways in human islets. Diabetes 47:758-763, 1998
11. Squires PE, Harris TE, Persaud SJ, Curtis SB, Buchan AM, Jones PM: The extracellular calcium-sensing receptor on human β-cells negatively modulates insulin secretion. Diabetes 49:409-417, 2000
12. Gravena C, Mathias PC, Ashcroft SJH: Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J Endocrinol 173:73-80, 2002
13. Davalli AM, Ricordi C, Socci C, Braghi S, Bertuzzi F, Fattor B, Di Carlo V, Pontiroli AE, Pozza G: Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 72:202-208, 1991
14. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A: Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci U S A 91:9253-9256, 1994
15. Ling Z, Pipeleers DG: Prolonged exposure of human β-cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805-2812, 1996
16. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML: Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270:C1581-C1587, 1996
17. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, Cerasi E, Melloul D: Impaired β-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48:1230-1236, 1999
18. i abnormalities in human pancreatic islets: important role of overstimulation. Diabetes 49:1840-1848, 2000
19. KB repressor. J Biol Chem 275:36509-36513, 2000
20. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY: Glucose-induced β-cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860, 2002
21. Song SH, Rhodes CJ, Veldhuis JD, Butler PC: Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. Endocrinology 144:3399-3405, 2003
22. 2 in the modulation of insulin secretion. Am J Physiol 286:E560-E567, 2004
23. Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ: Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 37:177-181, 1994
24. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B, Barker CF, Naji A, Matschinsky FM, Markmann JF: Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624-632, 2004
25. Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U, Del Prato S, Rabuazzo AM, Purrello F, Marchetti P: Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48:282-289, 2005
26. Dufrane D, Goebbels RM, Guiot Y, Squifflet JP, Henquin JC, Gianello P: A simple method using a polymethylpenten chamber for isolation of human pancreatic islets. Pancreas 30:e51-e59, 2005
27. Warnotte C, Nenquin M, Henquin JC: Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153:147-153, 1999
28. 2+ and amplification signals in β-cells. Diabetes 55:441-451, 2006
29. + channel in human pancreatic islet cells. Diabetes 38:422-427, 1989
30. Ashcroft FM, Kakei M, Gibson JS, Gray DW, Sutton R: The ATP- and tolbutamide-sensitivity of the ATP-sensitive K-channel from human pancreatic β-cells. Diabetologia 32:591-598, 1989
31. Henquin JC: Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760, 2000
32. Van Loon LJC, Saris WHM, Verhagen H, Wagenmakers AJM: Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr 72:96-105, 2000
33. Li C, Buettger C, Kwagh J, Matter A, Daikhin Y, Nissim IB, Collins HW, Yudkoff M, Stanley CA, Matschinsky FM: A signaling role of glutamine in insulin secretion. J Biol Chem 279:13393-13401, 2004
34. MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA: Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am J Physiol 288:E1-E15, 2005
35. Bertrand G, Ishiyama N, Nenquin M, Ravier MA, Henquin JC: The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related. J Biol Chem 277:32883-32891, 2002
36. Parker SM, Moore PC, Johnson LM, Poitout V: Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate. Metabolism 52:1367-1371, 2003
37. MacDonald MJ: Differences between mouse and rat pancreatic islets: succinate responsiveness, malic enzyme, and anaplerosis. Am J Physiol 283:E302-E310, 2002
38. Jijakli H, Bakkali Nadi A, Cook L, Best L, Sener A, Malaisse WJ: Insulinotropic action of methyl pyruvate: enzymatic and metabolic aspects. Arch Biochem Biophys 335:245-257, 1996
39. ATP channels, and not as a mitochondrial substrate. Biochem J 368:817-825, 2002
40. Capito K, Hedeskov CJ: Inosine-stimulated insulin release and metabolism of inosine in isolated mouse pancreatic islets. Biochem J 158:335-340, 1976
41. Bozem M, Garrino MG, Henquin JC: Inosine partially mimics the effects of glucose on ionic fluxes, electrical activity, and insulin release in mouse pancreatic β-cells. Pflügers Arch 410:457-463, 1987
42. Cerasi E: Mechanisms of glucose stimulated insulin secretion in health and in diabetes: some re-evaluations and proposals. Diabetologia 11:1-13, 1975
43. Rudenski AS, Hosker JP, Burnett MA, Matthews DR, Turner RC: The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. Metabolism 37:526-534, 1988
44. Polonsky KS: Lilly Lecture 1994: The β-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717, 1995
45. Van Haeften TW, Boonstra E, Veneman TF, Gerich JE, van der Veen EA: Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release. Metabolism 39:1292-1299, 1990
46. Davalli AM, Pontiroli AE, Socci C, Bertuzzi F, Fattor B, Braghi S, Di Carlo V, Pozza G: Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than β-cell exhaustion. J Clin Endocrinol Metab 74:790-794, 1992
47. Byrne MM, Sturis J, Polonsky KS: Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 268:E21-E27, 1995
48. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J: The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55:1-12, 2006
49. Bedoya FJ, Wilson JM, Ghosh AK, Finegold D, Matschinsky FM: The glucokinase glucose sensor in human pancreatic islet tissue. Diabetes 35:61-67, 1986
50. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F: Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489-2495, 1995
51. Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schuit F, Henquin JC: The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in β-cells but not in α-cells and are also observed in human islets. J Biol Chem 273:33905-33908, 1998
52. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988
53. Lenzen S: Insulin secretion by isolated perfused rat and mouse pancreas. Am J Physiol 236:E391-E400, 1979
54. Berglund O: Different dynamics of insulin secretion in the perfused pancreas of mouse and rat. Acta Endocrinol 93:54-60, 1980
55. Zawalich WS, Bonnet-Eymard M, Zawalich KC: Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets. Metabolism 49:1156-1163, 2000
56. Curry DL, Bennett LL, Grodsky GM: Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83:572-584, 1968
57. Nunemaker CS, Wasserman DH, McGuinness OP, Sweet IR, Teague JC, Satin LS: Insulin secretion in the conscious mouse is biphasic and pulsatile. Am J Physiol 290:E523-E529, 2006
58. Efendic S, Cerasi E, Luft R: Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects. Diabetes 23:161-171, 1974
59. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr: Diminished B-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328, 1984
60. Ishiyama N, Ravier MA, Henquin JC: Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. Am J Physiol 290:E540-E549, 2006
61. Pfeifer MA, Halter JB, Graf R, Porte D Jr: Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes 29:335-340, 1980
62. Boden G, Chen X: Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes 48:577-583, 1999